Literature DB >> 6236080

Structure and interactions of heparan sulfate proteoglycans from a mouse tumor basement membrane.

S Fujiwara, H Wiedemann, R Timpl, A Lustig, J Engel.   

Abstract

Various forms of heparan sulfate proteoglycan were solubilized from the mouse Engelbreth-Holm-Swarm (EHS) sarcoma by extraction with 0.5 M NaCl, collagenase digestion and extraction with 4 M guanidine. They could be separated into high (greater than or equal to 1.65 g/ml) and low (1.38 g/ml) buoyant density variants. The high-density form from the NaCl extract and collagenase digest had Mr = 130000 and So20,W = 4.5 S and contained 4-10% protein, indicating Mr = 5 000-12 000 for the protein core. This proteoglycan exhibited polydispersity as shown by rotary shadowing electron microscopy and ultracentrifugation. An average molecule consisted of four heparan sulfate chains (Mr = 29 000) each with a length of 32 +/- 10 nm. The low-density form (Mr about 400 000) could not be completely purified and contained about 50% protein. As shown by radioimmunoassay, the various proteoglycans shared similar protein cores. Labeling of the tumor in vivo or in vitro demonstrated preferential incorporation of radioactive sulfate in the high-density form. The high-density proteoglycan interacted in affinity chromatography by virtue of its heparan sulfate chains with laminin, fibronectin, the globular domain NC1 and the triple helix of collagen IV. These interactions were abolished at moderate concentrations of NaCl (0.1-0.2 M) and in the presence of heparin, chondroitin sulfate or dextran sulfate. Interactions with the globule NC1 could also be demonstrated by velocity band centrifugation in sucrose gradients and a binding constant of about 10(6) M-1 was derived.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6236080     DOI: 10.1111/j.1432-1033.1984.tb08353.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  47 in total

1.  Kinetic analysis of the effects of glycosaminoglycans and lipoproteins on urokinase-mediated plasminogen activation.

Authors:  J M Edelberg; M Weissler; S V Pizzo
Journal:  Biochem J       Date:  1991-06-15       Impact factor: 3.857

2.  Basement-membrane heparan sulphate with high affinity for antithrombin synthesized by normal and transformed mouse mammary epithelial cells.

Authors:  G Pejler; G David
Journal:  Biochem J       Date:  1987-11-15       Impact factor: 3.857

Review 3.  Interactions between cancer cells and the microvasculature: a rate-regulator for metastasis.

Authors:  L Weiss; F W Orr; K V Honn
Journal:  Clin Exp Metastasis       Date:  1989 Mar-Apr       Impact factor: 5.150

4.  Basement membrane heparan sulfate proteoglycans are concentrated in the laminae rarae and in podocytes of the rat renal glomerulus.

Authors:  J L Stow; H Sawada; M G Farquhar
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

Review 5.  Structure and function of heparan sulphate proteoglycans.

Authors:  J T Gallagher; M Lyon; W P Steward
Journal:  Biochem J       Date:  1986-06-01       Impact factor: 3.857

6.  Type IV collagen lateral associations in the EHS tumor matrix. Comparison with amniotic and in vitro networks.

Authors:  P D Yurchenco; G C Ruben
Journal:  Am J Pathol       Date:  1988-08       Impact factor: 4.307

7.  Glycosaminoglycans in human gallbladder basement membrane: nature and quantitative changes in chronic cholecystitis.

Authors:  K A Hussein; G Milne; D Hopwood
Journal:  Histochem J       Date:  1988-08

8.  Association of laminin with heparan and chondroitin sulfate-bearing proteoglycans in neurite-promoting factor complexes from rat schwannoma cells.

Authors:  G E Davis; F G Klier; E Engvall; C Cornbrooks; S Varon; M Manthorpe
Journal:  Neurochem Res       Date:  1987-10       Impact factor: 3.996

Review 9.  Antigens of the human glomerular basement membrane.

Authors:  L S Fouser; A F Michael
Journal:  Springer Semin Immunopathol       Date:  1987

10.  Tissue distribution of amyloid P component as defined by a monoclonal antibody produced by immunization with human glomerular basement membranes.

Authors:  H al-Mutlaq; J Wheeler; H Robertson; C Watchorn; A R Morley
Journal:  Histochem J       Date:  1993-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.